Primera Analytical Solutions Corporation
Duo (Carina) Zhang is a Scientist III at Primera Analytical Solutions Corporation since November 2022, specializing in the analysis of raw materials, in-process samples, and finished goods in accordance with GLP regulations. Previously, as a Senior Scientist I at Accuredit Therapeutics from March 2022 to October 2022, Duo led projects focused on lipid nanoparticle-encapsulated RNA drugs and conducted methodology development for quantification of sgRNA and Cas9mRNA from blood samples. Duo's early career involved serving as a Research Assistant Graduate Student at the University of Iowa from August 2016 to March 2022, where methodologies were developed for the extraction and quantification of PCB sulfates in human serum, as part of the Iowa Superfund Research Program. Duo earned a Doctor of Philosophy in Toxicology in December 2021 and a Bachelor of Science in Biochemistry in December 2015, both from the University of Iowa.
This person is not in any offices
Primera Analytical Solutions Corporation
Primera Analytical Solutions is a GLP and GMP CRO in great standing with the FDA. Our primary objectives are quality and to become a trusted partner. Services include: - Large and small molecule CMC, bioanalytical, release testing. Method development/validation, method transfer (Assay, Impurities, Dissolution, PK/PD, ADA, cell-based/non cell-based NAb) - Cell & Gene Therapy (FACS, qPCR, ddPCR, cell-based assays - Cell potency assays - Impurity studies (LC/MS/MS, GC/MS, ICP/MS) - Extractable and leachable studies - Stability studies - Dissolution - Abuse-deterrent studies - Solid state characterization - Product and raw material release testing - Metabolite characterization, bioavailability and bioequivalence studies - Bioassay method development and validation - Impurities by ELISA - Peptide mapping - HRMS